SCHEMBL2275122

SCHEMBL2275122

Cc1cc(Cc2ccccc2)nc(NC2CCN(c3ccnc(C)n3)CC2)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCR4 P61073 1/20 0.46
HRH4 Q9H3N8 7/20 0.45
MEN1 O00255 2/20 0.45
ALDH1A1 P00352 2/20 0.45
KMT2A Q03164 2/20 0.45
LMNA P02545 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
OGA O60502 2/20 0.44
LCK P06239 3/20 0.44
ITK Q08881 3/20 0.44
AURKB Q96GD4 3/20 0.43
PLK4 O00444 1/20 0.43
PAK4 O96013 1/20 0.43
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C19 P33261 1/20 0.40
HTT P42858 1/20 0.40
POLB P06746 1/20 0.40
ACHE P22303 1/20 0.39
BACE1 P56817 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6908522 0.82 LCK (0.46) HRH4MEN1ALDH1A1KMT2ALMNA
Hydrochloric Acid SCHEMBL2269906 0.82 LCK (0.45) HRH4MEN1ALDH1A1KMT2ALMNA
SCHEMBL2271659 0.81 LCK (0.44) HRH4MEN1ALDH1A1KMT2ALMNA
SCHEMBL2361667 0.80 LCK (0.46) HRH4MEN1ALDH1A1KMT2ALMNA
SCHEMBL2273839 0.78 LCK (0.47) HRH4MEN1ALDH1A1KMT2ALMNA
SCHEMBL2271494 0.77 LCK (0.45) HRH4MEN1ALDH1A1KMT2ALMNA
SCHEMBL2278914 0.77 LCK (0.44) HRH4MEN1ALDH1A1KMT2ALMNA
SCHEMBL2275717 0.77 HRH4 (0.48) HRH4MEN1ALDH1A1KMT2ALMNA
SCHEMBL2275711 0.77 HRH4 (0.48) HRH4MEN1ALDH1A1KMT2ALMNA
Hydrochloric Acid SCHEMBL2275336 0.75 PLK4 (0.66) LMNASMN1; SMN2LCKITKAURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8486967-B2 Heteroaryl substituted piperidines HOFFMANN-LA ROCHE INC. (US) 2013-07-16 US disclosed
US-8486967-B2 Heteroaryl substituted piperidines HOFFMANN-LA ROCHE INC. (US) 2013-07-16 US disclosed
EP-2536710-A2 PIPERIDINE DERIVATIVES F. Hoffmann-La Roche AG (CH) 2012-12-26 EP disclosed
US-20110201605-A1 HETEROARYL SUBSTITUTED PIPERIDINES HOFFMANN-LA ROCHE, INC. 2011-08-18 US disclosed
US-20110201605-A1 HETEROARYL SUBSTITUTED PIPERIDINES HOFFMANN-LA ROCHE, INC. 2011-08-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110201605-A1 HETEROARYL SUBSTITUTED PIPERIDINES APP, HPGDS, PSEN1 CXCR4 2231/4885HRH4 134/4885MEN1 2633/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.